#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA884268	Binding	Inhibition of [3H]apomorphine binding to calf caudate membrane preparation (p4)		17	ALA1121759	assay format	Scientific Literature
2.	ALA654452	Binding	Inhibition of [3H]spiroperidol binding to calf caudate membrane preparation (p4)		17	ALA1121759	assay format	Scientific Literature
3.	ALA672894	Functional	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain hemispheral area by po administration	Rattus norvegicus	3	ALA1126882	organism-based format	Scientific Literature
4.	ALA672895	Functional	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain hemispheral area by po administration; Inactive	Rattus norvegicus	2	ALA1126882	organism-based format	Scientific Literature
5.	ALA672896	Functional	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain hemispheral area by sc administration; Inactive	Rattus norvegicus	8	ALA1126882	organism-based format	Scientific Literature
6.	ALA672897	Functional	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain hemispheral area by sc administration; Partial response at the highest dose tested	Rattus norvegicus	1	ALA1126882	organism-based format	Scientific Literature
7.	ALA668257	Functional	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain hemispheral area by sc administration; partial response at the highest dose tested	Rattus norvegicus	2	ALA1126882	organism-based format	Scientific Literature
8.	ALA668258	Functional	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain limbic area by po administration	Rattus norvegicus	4	ALA1126882	organism-based format	Scientific Literature
9.	ALA668259	Functional	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain limbic area by po administration; partial response at the highest dose tested	Rattus norvegicus	1	ALA1126882	organism-based format	Scientific Literature
10.	ALA669500	Functional	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain limbic area by sc administration	Rattus norvegicus	7	ALA1126882	organism-based format	Scientific Literature
11.	ALA669501	Functional	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain limbic area by sc administration; Inactive	Rattus norvegicus	2	ALA1126882	organism-based format	Scientific Literature
12.	ALA669502	Functional	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain limbic area by sc administration; partial response at the highest dose tested	Rattus norvegicus	3	ALA1126882	organism-based format	Scientific Literature
13.	ALA669503	Functional	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain striatal area by po administration	Rattus norvegicus	4	ALA1126882	organism-based format	Scientific Literature
14.	ALA669504	Functional	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain striatal area by po administration; partial response at the highest dose tested	Rattus norvegicus	1	ALA1126882	organism-based format	Scientific Literature
15.	ALA669505	Functional	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain striatal area by sc administration	Rattus norvegicus	7	ALA1126882	organism-based format	Scientific Literature
16.	ALA669506	Functional	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain striatal area by sc administration; Inactive	Rattus norvegicus	2	ALA1126882	organism-based format	Scientific Literature
17.	ALA669507	Functional	Effective dose for half-maximal decrease in the accumulation of DOPA in reserpinized rat brain striatal area by sc administration; partial response at the highest dose tested	Rattus norvegicus	3	ALA1126882	organism-based format	Scientific Literature
18.	ALA669517	Functional	Compound was evaluated for its ability to inhibit Striatal Dopamine Receptor in rat brain through radioreceptor assay carried out with agonist ligand.		5	ALA1125726	tissue-based format	Scientific Literature
19.	ALA672973	Binding	Compound is tested for its ability to displace Di-Pr-5,6-ADTN at 0.25 umol/kg subcutaneous dose from rat striatal binding sites in vivo		1	ALA1127438	organism-based format	Scientific Literature
20.	ALA672974	Binding	Ability to displace the DA receptor agonist DiPr-5,6-ADTN from rat striatal binding sites in vivo at a dose of 40 uM/kg by subcutaneous administration		1	ALA1123708	organism-based format	Scientific Literature